WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

Saved in:

Bibliographic Details
Main Authors:	Lucia Quintana-Gallardo, Andrew Bomback, Erica Daina, John Kanellis, David Kavanagh, Matthew C. Pickering, Gere Sunder-Plassmann, Patrick Walker, Zhongshen Wang, Zurish Ahmad, Fadi Fakhouri
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924003759
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis
by: Andrew S. Bomback, et al.
Published: (2025-01-01)

Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy
by: Andrew S. Bomback, et al.
Published: (2025-01-01)

Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis
by: Matthieu Halfon, et al.
Published: (2025-01-01)

WCN24-1146 SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
by: Nicholas Webb, et al.
Published: (2024-04-01)

C3 Glomerulopathy: Novel Treatment Paradigms
by: Blanca Tarragon Estebanez, et al.
Published: (2024-03-01)

Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
by: Fernando Caravaca-Fontán, et al.
Published: (2025-04-01)

Anticomplement Therapies for C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis Recurrence - A Dawn of New Hope
by: Francesco Emma, et al.
Published: (2025-01-01)

WCN24-2435 CLINICAL CHARACTERISTICS OF PATIENTS WITH C3 GLOMERULOPATHY AND IDIOPATHIC MEMBRANOPROLIFERATIVE IMMUNE COMPLEX GLOMERULONEPHRITIS IN A HOSPITAL IN ARGENTINA
by: Lucas Ramos, et al.
Published: (2024-04-01)

Clinical characteristics and short term outcomes of childhood immune complex membranoproliferative glomerulonephritis and C3 glomerulopathy: a single centre retrospective study
by: Irshad Ali Bajeer, et al.
Published: (2025-03-01)

WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
by: Carla Nester, et al.
Published: (2025-02-01)

C3 glomerulopathy is highly prevalent in French Polynesia
by: Nelly Candela, et al.
Published: (2024-12-01)

What influences people’s decision to participate in clinical trials? A qualitative interview study with patients and parents of patients diagnosed with primary membranoproliferative glomerulonephritis (MPGN)
by: Rebecca Bruu Carver, et al.
Published: (2024-01-01)

Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study
by: Marina Vivarelli, et al.
Published: (2024-01-01)

C3 Glomerulopathy: A Current Perspective in an Evolving Landscape
by: Eric Keoni Magliulo, et al.
Published: (2024-10-01)

The Role of von Willebrand Factor in the Pathogenesis of C3 Glomerulopathy
by: Zixin Hua, et al.
Published: (2025-06-01)

Pregnancy outcomes in C3 glomerulopathy: a retrospective review
by: Lauren O. Fergus, et al.
Published: (2025-05-01)

Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
by: Carla M. Nester, et al.
Published: (2025-02-01)

C3 glomerulopathy triggered by infection-A rare case report
by: Diksha Samsukha, et al.
Published: (2025-08-01)

Analysis of pathological features related to clinical prognosis in C3 glomerulopathy
by: ZHANG Junhua, LI Yilin, XIE Jingyuan, ZHANG Chunli, XU Jing
Published: (2024-12-01)

C3 glomerulopathy in children: experience at a resource-limited center
by: Soumya Reddy, et al.
Published: (2025-04-01)

Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy
by: Alistair Baber, et al.
Published: (2024-03-01)

Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy
by: Jill J. Hauer, et al.
Published: (2024-02-01)

Mycoplasma pneumoniae Infection Associated C3 Glomerulopathy Presenting as Severe Crescentic Glomerulonephritis
by: Lalani De Silva, et al.
Published: (2021-01-01)

C3 glomerulopathy associated with mycoplasma pneumoniae infection and positive IgA staining
by: Zhi-Yu Duan, et al.
Published: (2025-02-01)

WCN25-2675 C3 GLOMERULOPATHY RARE DISEASE AND NEW THERAPUTIC APPROACH
by: Emad Khater, et al.
Published: (2025-02-01)

WCN24-818 MPGN RELATED TO SALMONELLA INFECTION
by: NIHAL BASHIR, et al.
Published: (2024-04-01)

Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy
by: Amanda K. Slagle, et al.
Published: (2025-05-01)

Overcoming Complexities in Renal Transplantation: A Case of C3 Glomerulopathy, Antiphospholipid Syndrome, and Lithium Toxicity
by: Arun Narayana Kumar, et al.
Published: (2025-01-01)

WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT
by: Briana Ndife, et al.
Published: (2024-04-01)

WCN24-551 CKD PROGRESSION IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT
by: Briana Ndife, et al.
Published: (2024-04-01)

WCN25-4316 CLINICAL PROFILE AND TREATMENT OUTCOMES OF IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AND C3 GLOMERULONEPHRITIS IN A TERTIARY CARE CENTER
by: Tonmay Barai, et al.
Published: (2025-02-01)

Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy
by: Leo Starck, et al.
Published: (2025-03-01)

Early Recurrence of C3 Glomerulopathy Postrenal Transplant Manifesting as Atypical Hemolytic Uremic Syndrome: A Phenotype Switch
by: Vishwanath Siddini, et al.
Published: (2024-12-01)

Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
by: Brian Mulherin, et al.
Published: (2024-10-01)

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
by: Ryan L. Crass, et al.
Published: (2024-11-01)

Identification of c.683_684insCTGCAAGGACAAATCTGACGA pathogenic variant of the low-density lipoprotein receptor gene in a patient with familial hypercholesterolemia: a case report
by: V. A. Korneva, et al.
Published: (2023-09-01)

Hepatitis C Eradication and Improvement of Cryoglobulinemia-Associated Rash and Membranoproliferative Glomerulonephritis with Interferon and Ribavirin after Kidney Transplantation
by: Marilyn Zeman, et al.
Published: (2006-01-01)

Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy
by: Jessica Cruz-Whitley, et al.
Published: (2020-01-01)

Repeated Kidney Biopsy in Membranoproliferative Glomerulonephritis
by: Ai-Hui Li, et al.
Published: (2025-01-01)

Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction
by: Irmela Mantel, et al.
Published: (2025-02-01)